PULBOROUGH MEDICAL GROUP
SPIRO CLOSE, PULBOROUGH
Stroke 12
The % of patients with a stroke shown to be non-haemorrhagic, or a history of TIA, who have a record that an anti-platelet agent (aspirin, clopidogrel, dipyridamole or a combination), or an anti-coagulant is being taken (unless a contraindication or side-effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| Stroke 12 | 2008 | 177 | 204 | 86.8% | |
| Stroke 12 | 2009 | 173 | 194 | 89.2% | |
| Stroke 12 | 2010 | 161 | 178 | 90.4% | |
| STROKE 12 | 2011 | 154 | 171 | 90.1% | |
| STROKE 12 | 2012 | 156 | 174 | 89.7% | |
| STROKE 12 | 2013 | 161 | 177 | 91.0% | |
| STIA007 | 2014 | 177 | 179 | 98.9% | |
| STIA007 | 2015 | 188 | 190 | 98.9% | |
| STIA007 | 2016 | 194 | 198 | 98.0% | |
| STIA007 | 2017 | 203 | 206 | 98.5% | |
| STIA007 | 2018 | 193 | 197 | 98.0% | |
| STIA007 | 2019 | 203 | 207 | 98.1% | |
| STIA007 | 2020 | 218 | 226 | 96.5% | |
| STIA007 | 2021 | 221 | 246 | 89.8% | |
| STIA007 | 2022 | 231 | 235 | 98.3% | |
| STIA007 | 2023 | 226 | 257 | 87.9% |
